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1 Genistein is a tyrosine kinase inhibitor which interferes with the activity of several ionic channels
either by altering modulatory phosphorylating processes or by direct binding. In whole-cell
conditions, genistein induces a partial inhibition of the pacemaker (If) current recorded in cardiac
sinoatrial and ventricular myocytes.
2 We investigated the mechanism of action of genistein (50 mM) on the If current in whole-cell, cell-
attached, and inside-out configurations, and the measured fractional inhibitions were similar: 26.6,
27.2, and 33.6%, respectively.
3 When ATP was removed from the whole-cell pipette solution no differences were revealed in the
effect of the drug when compared to metabolically active cells. Genistein fully maintained its blocking
ability even when herbimycin, a tyrosine kinase inhibitor, was added to the whole-cell ATP-free
pipette solution.
4 Genistein-induced block was independent of the gating state of the channel and did not display
voltage or current dependence; this independence distinguishes genistein from all other f-channel
blockers.
5 When inside-out experiments were performed to test for a direct interaction with the channel,
genistein, superfused on the intracellular side of the membrane, decreased the maximal If conductance,
and slightly shifted the current–activation curve to the left. Furthermore, the effect of genistein was
independent of cAMP modulation.
6 We conclude that, in addition to its tyrosine kinase-inhibitory properties, genistein also blocks
If by directly interacting with the channel, and thus cannot be considered a valuable pharmacological
tool to investigate phosphorylation-dependent modulatory pathways of the If current and of cardiac
rhythm.
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Introduction
The hyperpolarization-activated current (If) is essential to the
initiation of cardiac spontaneous activity in sinoatrial node
(SAN) myocytes, where it provides an inward current that
sustains the pacemaker depolarization phase (DiFrancesco,
1993; Robinson & Siegelbaum, 2003; Baruscotti & DiFran-
cesco, 2004). Due to this functional role, any pathway that
modulates the sinoatrial If availability also modifies the slope
of the diastolic depolarization, and thus heart rate. Two main
mechanisms involved in the modulation of cardiac If current
have extensively been investigated by several groups: while one
mechanism is a direct binding of the second messenger cAMP
to the f-channel (DiFrancesco & Tortora, 1991), a second
indirect mechanism is mediated by phosphorylation-dependent
processes (Chang et al., 1991; Wu et al., 2000). The action of
the cAMP-dependent modulation relies on the allosteric
binding of four cAMP molecules to the channel and results
in a shift of the activation curve with no change in maximal or
single-channel conductance (DiFrancesco, 1999). The struc-
tural identification of the site of interaction between the
channel and the second messenger has been possible after the
cloning of the hyperpolarization-activated cyclic nucleotide-
gated (HCN) channel family (Santoro & Tibbs, 1999) and the
crystallography of the cyclic nucleotide domain (Zagotta et al.,
2003). The importance of phosphorylation-mediated modula-
tions on If has been demonstrated by several experiments.
Calyculin A, a type I and II phosphatase inhibitor, increases If
by increasing its maximal conductance, with no significant
changes in the voltage dependence of the activation curve
(Accili et al., 1997). Although a change in single-channel
conductance cannot be ruled out, the most likely interpretation
of these results is that phosphorylation-dependent processes
are an important step in the enhancement of the density of
functional proteins in the plasma membrane (Corey et al.,
1994; Accili et al., 1997). Further evidence in support of a
specific tyrosine-kinase phosphorylation-dependent pathway
comes from experiments conducted on SAN myocytes, where
the activity of tyrosine kinases was either inhibited (Wu*Author for correspondence; E-mail: mirko.baruscotti@unimi.it
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& Cohen, 1997) or induced (Wu et al., 2000), and these actions
resulted in the modulation of the If current.
Genistein is an isoflavone compound originally isolated
from the fermentation broth of Pseudomonas sp and char-
acterized as a tyrosine kinase inhibitor, which competes for the
ATP-binding site with an IC50 of 20.4–111 mM (Akiyama et al.,
1987; Akiyama & Ogawara, 1991). Several authors have
exploited this property to show that genistein reduces maximal
conductance in native If current (Wu & Cohen, 1997) and
inhibits HCN2 and HCN4 isoforms, although with different
effects (Yu et al., 2004). In agreement with a functionally
relevant If block are the results by Ma et al. (2002) showing
that, when tested in intact SAN tissue preparations, genistein
(50mM) reduced the rate of contraction via a reduction of the
slope of the diastolic depolarization. Additional studies
indicate that genistein can modify the activity of several types
of channels by mechanisms not involving inhibition of
tyrosine-kinase activity. For example, genistein has been
shown to directly block neuronal voltage-dependent Naþ
channels (Paillart et al., 1997), and similarly reduces the L-type
calcium current both in rat (Yokoshiki et al., 1996) and in
guinea-pig ventricular myocytes, where it also potentiates the
cAMP-dependent chloride current (Chiang et al., 1996). A
direct interaction with the channel has also been suggested for
cystic fibrosis transmembrane conductance regulator (CFTR)
chloride channels (Weinreich et al., 1997). The concentration–
response curves for these effects are largely overlapping with
the one of tyrosine kinase inhibition: hence, a separation
between the latter effect and channel block is not possible by
adjusting the concentration of the drug. Preliminary sugges-
tions that genistein could modulate the If current through a
phosphorylation-independent mechanism have come from
whole-cell studies by Shibata et al. (1999), but a thorough
investigation and a definitive evidence is still missing. We have
therefore addressed the possibility of a direct interaction
between the molecule and the f-channel by comparing the
effect of genistein in whole-cell, cell-attached, and inside-out
experiments. Our experiments indicate that genistein is a
voltage-independent inhibitor of the If current that acts from
the intracellular side of the membrane and fully maintains its
ability to block f-channels even when metabolic activity is
uncoupled from channel activity. We therefore conclude that a
direct channel–drug interaction must take place in the
cytoplasmic-facing region of the channel. Therefore, genistein
cannot be utilized to selectively identify phosphorylation-
mediated modulatory processes of the pacemaker If current.
Methods
Animal protocols conformed to the guidelines of the care and
use of laboratory animals established by Italian (DL. 116/1992)
and European directives (86/609/CEE).
Cell isolation
The methods employed in this study to isolate SAN myocytes
from rabbit hearts have been previously described in detail
(DiFrancesco et al., 1986). New Zealand rabbits (0.8–1.2 kg)
were anaesthetized by i.m. injection of a mixture of xilazine
(4.6mg kg1) and ketamine (60mg kg1), killed by cervical
dislocation, and exsanguinated. After removal, hearts were
placed in prewarmed (371C) normal Tyrode solution (mM:
NaCl, 140; KCl, 5.4; CaCl2, 1.8; MgCl2, 1; D-glucose, 5.5;
Hepes-NaOH, 5; pH 7.4) containing 0.5ml heparin
(1000Uml1), and the SAN region exposed. The isolated
SAN tissue was then cut into strips which were initially rinsed
for 3min in a Ca2þ -free solution (mM: NaCl, 140; KCl, 5.4;
MgCl2, 0.5; KH2PO4, 1.2; D-glucose, 5.5; taurine, 50; Hepes-
NaOH, 5; pH 6.9) to loosen intercellular interactions.
Following this initial treatment, type I collagenase
(224Uml1), elastase (1.9Uml1), protease (0.6Uml1),
bovine serum albumin (BSA, 1mgml1), and CaCl2 (200mM)
were added to the solution to induce enzymatic dissociation
that normally lasted 12–25min at 371C. The strips were then
rinsed in a Ca2þ -free solution (mM: KCl, 20; glutamic acid, 70;
b-hydroxybutyric acid (sodium salt), 10; KH2PO4, 10; taurine,
10; Hepes-KOH, 5; KOH, 80; BSA 1mgml1; pH 7.4) to
remove traces of enzymes, and final cell dispersion was
obtained by mechanically shaking the strips in a similar
solution. Ca2þ , Kþ , and Naþ concentrations were then
gradually adjusted to their final level. Cells were kept alive
and in optimal conditions by storing at 41C for the
experimental day.
Experimental conditions
Current recordings were obtained in three different configura-
tions of the patch-clamp technique: whole-cell, cell-attached,
and inside-out. The external solution used during whole-cell
experiments was a normal Tyrode solution (see Cell isolation),
save for BaCl2 (1mM) and MnCl2 (2mM) that were added to
block contaminating Kþ and Ca2þ currents. The intracellular
pipette solution contained (mM): NaCl, 10; K-aspartate, 130;
ATP (sodium salt), 2; MgCl2, 2; CaCl2 (pCa 7), 2; EGTA-
KOH, 5; Hepes-KOH, 10; pH 7.2. When SAN myocytes were
voltage clamped by the perforated-patch method (Horn &
Marty, 1988), amphotericin B (260mM) was dissolved in the
following intracellular pipette solution (mM): NaCl, 10;
K-aspartate, 130; MgCl2, 2; CaCl2, 0.4; EGTA-KOH, 1; Hepes-
KOH, 10; pH 7.2. In cell-attached macropatch experiments,
the external solution superfusing the cell was (mM): KCl, 130;
NaCl, 10; Hepes-NaOH, 5; (pH 7.4), while in inside-out
experiments the control solution superfusing the intracellular
side of the excised patches contained (mM): NaCl, 10;
potassium aspartate, 130; CaCl2, 2 (pCa 7); EGTA, 5;
Hepes-KOH, 10; pH 7.2. The patch-pipette solution used in
both configurations (cell-attached and inside-out) was a
modified external solution previously used by DiFrancesco
& Tortora (1991) to increase the size of the If current (mM):
NaCl, 70; KCl, 70; CaCl2, 1.8; MgCl2, 1; BaCl2, 1; MnCl2, 2;
Hepes-KOH, 5; pH 7.4. Genistein (Sigma Aldrich, Italy),
a tyrosine kinase inhibitor that competes for ATP-binding site
(Akiyama et al., 1987), was dissolved in dimethylsulfoxide
(DMSO) and diluted in test solutions to the desired
concentrations; herbimycin A (Sigma Aldrich, Italy), a specific
tyrosine kinase inhibitor, was dissolved in DMSO and diluted
in intracellular pipette solution at a final concentration of
35 mM (Wu & Cohen, 1997). DMSO was added to control
solutions in the same concentration used in test solutions
(lower than 0.1%). Control and test solutions were delivered to
the cells through a fast superfusion system. Currents were
recorded at room temperature (22–251C), and drug effects
were measured at steady state. When filled with internal
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solution, pipette resistance measured was 3–5MO. Macro-
patches containing hundreds of f-channels were formed using
large-tipped pipettes (0.5–2MO) as described previously
(DiFrancesco & Tortora, 1991). The data were acquired and
analyzed with a custom-made patch-clamp amplifier and
pClamp software (version 7, Axon U.S.A.).
Data analysis
The voltage dependence of If at steady state can be described
by the equation If (V)¼ gf (V)*(VVf)¼ gf,max*yN(V)*(VVf)
where gf (V) is the conductance, gf,max is the maximal
conductance, yN(V) is the steady-state activation parameter,
and Vf is the reversal potential. Steady-state I–V curves were
measured by applying 60 s long hyperpolarizing voltage ramps
(110mVmin1) from a holding potential of 35mV.
Conductance-voltage (gf (V)) relations were then obtained
from the above equation as ratios between steady-state I–V
curves (If(V)) and V–Vf, where Vf was set to 12.24mV
(DiFrancesco & Mangoni, 1994). Conductance curves were
fitted to the Boltzmann equation gf (V)¼ gf,max*yN(V)¼
gf,max*(1þ exp((VV1/2)/s)), where V1/2 is the half-maximal
voltage and s is the slope factor. When comparing different
sets of data, statistical analysis was performed with either the
Student’s t-tests or analysis of variance (ANOVA); significance
was set to Po0.05. Results are given as mean7s.e.m. values.
Results
Representative whole-cell If current traces recorded in isolated
rabbit SAN myocytes during hyperpolarizing steps to 75mV
(holding potential, 35mV) in the presence and absence of
externally applied genistein (50 mM) are shown in Figure 1a,
and the complete time course of genistein-induced block and
recovery is presented in Figure 1b. Similar experiments were
repeated both in ruptured (n¼ 6) and in perforated patch
(n¼ 5) conditions; since no significant differences in the block
amplitudes were revealed, the two groups were pooled
together. In a total of n¼ 11 cells, the steady-state current
reduction was 26.672.5%. Single exponential fitting of the
time course of block and unblock yielded time constant values
of 20.372.4 and 25.472.7 s, respectively.
Experiments such as those presented in Figure 1 confirm
that genistein (50 mM) partially blocks the If current; however,
they do not help to identify the pathways involved. Indeed, the
action of the drug could be fully mediated by the inhibition
of tyrosine kinase-dependent phosphorylation processes, but
other inhibitory pathways cannot be excluded. To evaluate this
latter possibility, we first proceeded with whole-cell experi-
ments in which ATP was removed from the intracellular
pipette solution, and the efficacy of genistein (50 mM) was
tested by two repetitive superfusions separated by 10min
(Figure 2a). Although this interval should be long enough to
allow for substantial washout of intracellular ATP, genistein
maintained its blocking ability even during the second
exposure, and the degree of block was similar during the first
(26.9%) and second exposures (28.8%). In Figure 2a, the
time course of the If amplitude and representative whole-cell
If traces (insets) are shown. Similar experiments yielded a
genistein-induced mean current decrease of 22.472.5% (n¼ 9)
upon the first application, and of 26.672.8% (n¼ 5) when it
was superfused a second time. Kinetic evaluation of block and
unblock reactions also confirmed a similar behavior between
first (ton 24.275.7 s, n¼ 7; toff 23.875.4 s, n¼ 5) and second
(ton 26.878.9 s, n¼ 4; toff 27.175.1 s, n¼ 3) genistein expo-
sures, and with whole-cell experiments in the presence of ATP.
To further support the finding of a metabolic independent
block observed during the second exposure to genistein,
herbimycin (35 mM), a potent tyrosine kinase inhibitor
(Fukazawa et al., 1991; Wu & Cohen, 1997), was added to
the ATP-free pipette solution, and the effect of genistein on the
If current was tested several minutes after establishing the
whole-cell condition, and after the current had reached a stable
level. Sample traces presented in Figure 2b were recorded
9min after the equilibration of the cytoplasm with the pipette
solution, and show that in the cell tested genistein was still able
to induce a 22.7% block. The same protocol was repeated in
several cells and drug effects were tested at least 6min after the
beginning of the experiments; the mean block observed was
22.973.2% (n¼ 5). In Figure 2c the mean If blocks induced by
genistein with the three pipette solutions tested are summar-
ized: ATP 2mM (26.672.5%, n¼ 11), ATP-free (26.672.8%,
n¼ 5), and ATP-free plus herbimycin 35mM (22.973.2%, n¼ 5);
statistical analysis did not reveal significative differences.
We next investigated whether genistein-induced block of
f-currents depended on the gating state of the channel (Figures
3 and 4).
Figure 3 shows an experiment specifically devised to test
whether genistein can block f-channels when they are
a
b
Figure 1 Genistein reduces the whole-cell If current. (a) If current
was elicited every 6 s by a 2-s hyperpolarizing step to 75mV from a
holding potential of 35mV. Sample traces recorded in control
solution (1), during superfusion of genistein (50 mM, 2) and after
washout (3) are shown. (b) Time course of If amplitude at 75mV;
the horizontal bar indicates the time of genistein superfusion (gen);
the calculated inhibition was 24.2%. Continuous line represents the
single exponential fitting of the onset (t¼ 17.3 s) and removal
(t¼ 27.4 s) of the block.
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maintained in the closed state. An initial brief period of
current–activation elicited by a train of activation/deactivation
steps (105mV*3 s/þ 5mV*0.75 s; 1/6Hz) in control condi-
tion was followed by a prolonged clamp of the cell at the
holding potential (35mV*72 s) to force all the f-channels in
the closed state. Genistein (50 mM) superfusion started at the
beginning of this steady-state clamp. After this period, and still
in the presence of the drug, the pulsing protocol was resumed.
When the first current trace recorded upon pulse resuming (b)
was compared to the last trace obtained in control conditions
(a), a significant decrease of current amplitude was evident
(b/a ratio of 0.63). No further reduction was observed during
the following pulses (c/b ratio of 1.01). This experimental
paradigm was applied to four cells, and the analysis yielded
values of 0.6870.03 and of 0.9970.01 for b/a and c/b ratios,
respectively. These results clearly indicate that genistein has
full access to its binding site even when channels are closed.
We then evaluated whether genistein can still block f-
channels when they are open and an inward current is flowing.
In Figure 4a, sample current traces activated by long
hyperpolarizing pulses at different potentials are shown;
genistein (50 mM) was applied at steady-state current–activa-
tion and it always induced an upward deflection of the trace,
indicating the development of the block. We then plotted the
steady-state drug-induced reductions obtained at different
membrane potentials and observed that values were not
significantly different, indicating a lack of voltage dependence
of the block (Figure 4b). The mean fractional block obtained
by averaging block values independently from the voltages was
27.970.7% (n¼ 29). This value is not different from that
obtained for closed channels (32.373.0%, n¼ 4), thus
indicating that genistein-induced block is not influenced by
the channel state.
The experiments presented so far show that genistein fully
exerts its If-blocking ability even when tyrosine kinase-depen-
dent phosphorylation was abolished or at least severely limited
(Figure 2), and that block was independent of channel state
(Figures 3 and 4). We then verified the possibility of alternative
inhibitory pathways by the next series of experiments.
We first investigated whether genistein exerts its action from
the extracellular environment or from the cytoplasmic side;
n=5n=11
n=5
a
b c
Figure 2 Action of genistein on whole-cell If in the absence of
intracellular ATP and PTK activity. (a) Time course of steady-state
If amplitudes at 75mV (holding potential, 35mV); horizontal
bars indicate duration of genistein superfusion (gen); genistein was
applied twice at an interval of 10min. Drug-induced If reductions
were 26.9 and 28.8% during the first and second exposures,
respectively. Sample If traces in control conditions (1,3) and during
superfusion of genistein (50 mM; 2,4) are shown in the insets.
(b) Current traces recorded at 95mV in control condition (cont)
was started (gen) 9min after superfusion of genistein (50 mM) and
after washout (ret). The pipette solution contained regular intra-
cellular solution plus herbimycin (35 mM) and no ATP. (c) Graph bar
showing the genistein-induced mean (7s.e.m.) If reductions
obtained with a regular intracellular pipette solution containing
ATP 2mM, no ATP, and no ATP plus herbimycin 35 mM; blocks
were 26.672.5% (n¼ 11), 26.672.8% (n¼ 5), and 22.973.2%
(n¼ 5), for the three conditions, respectively. All recordings started
at least 6min after establishing the whole-cell configuration. Blocks
were not significantly different.
a
b c
Figure 3 Genistein-induced block of closed f-channels. A train of
activating/deactivating steps (105mV*3 s/þ 5mV*0.75 s; 1/6Hz)
was delivered to the cell under study and stable If traces were
recorded (left). Current stimulation was then stopped for 72 s by
clamping the cell at the holding potential (35mV). Genistein
(50 mM) superfusion started at the beginning of this silent period, and
was maintained throughout the whole time of the experiment. Train
stimulation was then resumed (right). When traces recorded just
after the interruption (b) and at the end of the experiment (c) were
compared to the trace recorded just before the interruption (a), the
calculated ratios b/a and c/a were 0.63 and 0.64, respectively, while
the c/b ratio yielded a value of 1.01.
n=7 n=7 n=9 n=6
a
b
Figure 4 Genistein blocks If in a voltage independent way. (a) The
If current was elicited by hyperpolarizing pulses to the voltages
indicated and genistein (50mM) was applied only after steady-state
activation was reached. Evaluation of steady-state blocks yielded
values of 28.5, 29.4, and 27.8% for currents recorded at 85, 105,
and 125mV, respectively. (b) Mean7s.e.m.% block obtained at
different voltages (75, 85, 105, and 125mV) are plotted
against voltage; statistical analysis did not reveal any voltage
dependence of the block.
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experiments were carried out in macropatch cell-attached
conditions to verify that genistein, dissolved in the external
superfusing solution, could still block the channel (Figure 5a).
The degree of genistein-induced macro-patch If reduction
(27.277.6%, n¼ 8) and time constants of block and recovery
(21.174.8 s, n¼ 6, and 21.271.1 s, n¼ 3) in cell-attached
recordings were not significantly different from those observed
in whole-cell recordings. Since externally applied genistein
maintained its blocking efficacy also in cell-attached experi-
ments, we excluded that the blocking molecule could enter the
channel and access its binding site from the external vestibule.
We then evaluated the effects of genistein on If recorded in
inside-out membrane patches, since this recording configura-
tion allowed the complete control of the superfusing solution
which did not contain ATP. After patch excision, If was
recorded every 10 s by stepping to 125mV from a holding
potential of 35mV (Figure 5b); the very negative value of the
activating step was used to compensate for the well-known
hyperpolarized shift of the If activation curve observed in
excised membrane patches (DiFrancesco & Mangoni, 1994).
After testing for the integrity of the inside-out configuration by
exposure to cAMP (10 mM, 2), genistein (50 mM) was applied
for the first time to the cytoplasmic side of the patch, and a
rapid, fully reversible If block was elicited (3). The same patch
was exposed to genistein two more times and comparable
blocks were obtained; traces 4 and 5 (third exposure) were
recorded in control condition (4) and upon genistein super-
fusion (5) 300 s after the first exposure. Similar experiments
(n¼ 6 patches) yielded a mean block of 33.671.7% (n¼ 6), not
different from whole-cell results. Block and unblock rates were
fast when compared both to pulse frequency (0.1Hz) and drug
delivery; therefore, no quantification of the time course of
these processes was attempted as it was done for external drug
superfusion. The permanence of genistein-induced inhibition
of the If current and the fast kinetic of block onset and removal
in inside-out conditions clearly indicate that a direct inter-
action between the channel and the drug must take place.
f-Channels belong to the HCN channel family and, among
other properties, are characterized by the presence of a cAMP-
binding site at the intracellular C-terminus. Inside-out experi-
ments were devised to test for possible functional interactions
between cAMP and genistein. Representative current traces
(a, b) and the time course (c) of an excised inside-out
membrane patch sequentially exposed to different combina-
tions of genistein (50 mM) and cAMP (0.2 mM) are shown in
Figure 6. Upon cAMP superfusion the current increased by
47.2% in the absence (1, 2) and by 44.9% in the presence (3, 4)
of genistein-induced inhibition. When genistein was tested
upon previous cAMP activation (6, 7), it induced a fast and
reversible inhibition of the current (28.4%), which was
comparable to that obtained in the absence (1, 3) of cAMP
prestimulation (32.5%). Summary data relative to three
patches yielded a cAMP-induced current increase of If by
a
b
Figure 5 Action of genistein on If in cell-attached and inside-out
macropatches. (a) If recordings obtained in cell-attached conditions
during hyperpolarizations to 105mV in control solution (1),
superfusion of genistein (50mM; 2), and after washout (3); the
steady-state block was 24.3%. (b) If traces recorded in inside-out
conditions during hyperpolarizations to 125mV; the recordings
were taken at various times in control conditions (1, 4), during
superfusions of cAMP (10 mM; 2) and genistein (50 mM; 3, 5); traces 4
and 5 were recorded 300 s after traces 1, 2, and 3, and correspond
to the third exposure to the drug (second exposure not shown).
The holding potential was set for all recordings to 35mV and
activating steps delivered at 0.1Hz.
a b
c
Figure 6 Action of genistein on inside-out If in the presence of
cAMP. (a, b) If currents recorded during hyperpolarizations to
125mV applied every 10 s from a holding potential of 35mV; the
traces correspond to various times in control conditions and during
superfusion of genistein (50mM) either alone or in combination with
cAMP (0.2 mM), as shown in (c). (c) Time course of If amplitude at
125mV; horizontal bars indicate superfusion of the different
solutions.
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33.578.2 and 40.173.2% in the absence and presence of
genistein (not significantly different), and a genistein-induced
current decrease of 32.876.4 and 28.373.6% before and
during superfusion with cAMP (not significantly different).
Yu et al. (2004) have recently shown that genistein reduces
the currents induced by heterologous expression of both
HCN2 and HCN4 clones, although with different mechanisms;
no effects were observed for HCN1. We therefore investigated
the mechanism responsible for the If reduction, and in
particular whether it arises from a negative shift of the
current–activation curve, as in the case of HCN2, or from a
reduction of maximal conductance, as in the case of HCN4.
A ramp protocol (see Methods) was used for a detailed
quantification of the effect of genistein on the gf (V) relation.
As shown in Figure 7a, the current recorded in inside-out
patches at 145mV was reduced by genistein, indicating a
decrease in the maximal conductance of If. The conductances
curves (Figure 7b) obtained in control and in the presence of
the drug were fitted to a Boltzmann relation (see Methods),
and the following parameters were obtained: V1/2¼
127.0mV, s¼ 4.9 for control conditions, and 128.8mV,
s¼ 5.5mV in drug superfusion. In n¼ 6 experiments the
maximal conductance decreased by 16.771.4%, while the
mid-points of activation (V1/2) and the slope factors (s)
increased from 122.772.3 and 6.170.6mV to 124.172.4
and 6.870.5mV in control and in the presence of genistein; all
parameters were significantly modified by the drug treatment.
These data confirm that the drug inhibits the If current mainly
by decreasing the maximal conductance, with only a minor
change in its voltage dependence.
Genistein concentration–response curve was then deter-
mined in the range 3–200 mM in inside-out macropatches as
shown in Figure 8. The time course of steady-state If current
amplitudes recorded in control condition and in the presence
of different genistein concentrations is plotted in Figure 8b.
Sample traces extracted from these experiments are shown in
Figure 8a. The inhibitory effect of the drug was calculated for
each concentration and the data were plotted on a semilog
scale (Figure 8c). To avoid cumulative effects, increasing
concentrations of genistein were applied only after full
recovery of the current to control values, and each patch was
exposed to no more than three genistein concentrations. Hill
function fitting yielded a half-maximal effective concentration
(IC50) of 60.9 mM, a maximal fractional inhibition (ymax) of
0.90, and a Hill coefficient (nH) of 1.2.
Discussion
Genistein is a phytoestrogenic molecule of particular impor-
tance because of its cancer-preventive and cardioprotective
properties (Zielonka et al., 2003; Altavilla et al., 2004). Due
to its inhibitory action on the activity of tyrosine kinases,
genistein has been widely used to dissect modulatory pathways
based on phosphorylating events. In order to investigate
whether, in addition to knock down phosphorylation-
mediated effects, genistein can also affect If through an
alternative pathway, we have combined whole-cell, cell-
attached, and inside-out experiments.
As previously shown by other groups (Wu & Cohen, 1997;
Shibata et al., 1999), we have initially confirmed with whole-
cell experiments that genistein induces a partial and reversible
inhibition of If in SAN cells (Figure 1). Similar results were
also obtained by Wu et al. (2000), who have shown that the
stimulatory effect of epidermal growth factor (EGF) on If was
inhibited by the presence of genistein. The proposed mechan-
ism of action was based on an EGF-dependent activation of
protein tyrosine kinases (PTKs) that can phosphorylate and
therefore activate If channels. This cascade of events is
interrupted by the inhibitory action of genistein on PTKs.
Along with this possibility, it should also be considered that
genistein could have additional inhibitory actions independent
of their block of PTK activity. This hypothesis has been tested
by the experiments described in Figure 2, which show that
genistein retained its ability to block the f-channels also when
tyrosine phosphorylation was severely impaired by removing
ATP and adding herbimycin, a strong inhibitor of PTKs, to
the whole-cell pipette solution.
The time course of genistein action in our whole-cell
experiments is comparable to that observed for the genistein-
induced Naþ current block in neurons, which was attributed
a
b
Figure 7 Action of genistein on current– and conductance–voltage
relations. (a, top) Hyperpolarizing ramps from 35 to 145mV
were applied at a rate of 110mVmin1 to an inside-out membrane
patch. Note that time runs backward. (a, bottom) Steady-state I–V
relations in control solution and during superfusion of genistein
(50 mM) as indicated. (b) gf (V) curves obtained as detailed in
Methods in control and in the presence of genistein.
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to direct channel block (complete effect inB20 s; Paillart et al.,
1997). A relatively rapid and reversible inhibitory effect of
genistein was also observed on the L-type Ca2þ current, on the
delayed Kþ current, and on the inwardly rectifying Kþ
current in guinea-pig ventricular myocytes (Chiang et al.,
1996; 2002; Hool et al., 1998). Since calyculin A, a phosphatase
inhibitor, requires longer times to increase If (t¼ 466 s; Accili
et al., 1997), the time course of the action of genistein on If
found in our experiments is more compatible with a direct
blocking action than with de-phosphorylation via tyrosine
kinase inhibition. The noncatalytic dependent effect of
genistein on f-channels found in our experiments can be
compared to the genistein-induced inhibition of rod cyclic
nucleotide gated (CNG) channels, which was attributed by
Molokanova et al. (1999) to channel block independent of
phosphorylating reactions. These authors conclude that when
PTKs are bound to genistein, they can allosterically influence
gating of the rod channel, independent of their role in
catalyzing phosphorylation. However, the same authors have
observed that ATP decreases the effectiveness of genistein-
induced channel inhibition. In contrast, we did not notice a
dependence of the If block by genistein upon intracellular ATP.
Our whole-cell experiments strongly point to the existence of
a phosphorylation-independent blockade of the If current, as
was also observed by Shibata et al. (1999), who reported the
permanence of genistein block when PTK activity was
inhibited by tyrphostin 25. The whole-cell approach, though,
relies on the assumption that, after several minutes from the
formation of the whole-cell condition, intracellular ATP and
tyrosine kinase activity should be negligible, but it cannot be
fully excluded that partially inaccessible subcellular micro-
environments favor the persistence of localized phosphorylat-
ing pathways. Our experiments presented in Figure 5 make use
of a more direct approach (cell-attached and inside-out) to
demonstrate a direct interaction of genistein with f-channels at
the intracellular level. Indeed genistein acts on f-channels in
cell-attached experiments (Figure 5a), and steady-state block
occurs in less than 10 s (i.e. the interpulse interval), a value
comparable to that required for cAMP action in similar
conditions (B8 s; DiFrancesco & Tortora, 1991). Genistein
exerts a wide spectrum of actions which include tyrosine kinase
inhibition, direct block of ionic channels, and NO synthase
activity enhancement (Rathel et al., 2005); for this reason, the
dissection of single effects is extremely difficult. This situation
is further complicated by the fact that most of the concentra-
tion–response curves obtained for these genistein actions
yielded similar IC50 values (range 17.5–111 mM; Akiyama &
Ogawara, 1991; Chiang et al., 1996; Paillart et al., 1997), and
therefore a dissection of the effects based on drug concentra-
tion is nearly impossible. The concentration–response curve
shown in our Figure 8 yielded an IC50 value of 60.9 mM that
agrees well with those just mentioned and with that obtained
by Shibata et al. (1999) for the whole-cell If current (62.3 mM).
In our inside-out experiments, though, the extremely simplified
and controlled situation allows to conclude that genistein
directly acts on the f-channel. Interestingly, when a similar
concentration (50 mM) was tested on spontaneously beating
intact SAN preparations (Ma et al., 2002), it significantly
slowed the spontaneous rate of contraction by a selective
decrease of the slope of phase 4 with no modification of the
repolarization phase (Table 1 from Ma et al., 2002). A
significant decrease of the maximal upstroke velocity (Vmax)
was also observed. Although the authors did not thoroughly
investigate the molecular reasons for these effects, these data
are consistent with the inhibition of both If and ICaL currents.
Direct activation by cyclic nucleotides is a property shared
by f- and CNG channels. Since genistein is an inhibitory
agonist for the nucleotide-binding sites of PTKs (Akiyama &
Ogawara, 1991), we also hypothesized a possible interaction of
genistein with the cAMP-binding site of If channels. However,
we found that If modulation by cAMP was not modified by
genistein and that cAMP did not prevent the blocking effect of
the drug (Figure 6), and this suggests different sites of action.
Genistein is an unspecific ion channel blocker; indeed, in the
literature there are several reports that highlight the broad
range of blocking mechanisms and these include direct
blockade both at extracellular and intracellular sites. For
a
b
c
Figure 8 Concentration–response curve of the If current inhibition
by genistein. If was recorded in inside-out conditions during
hyperpolarizing steps to 125mV applied every 10 s (holding
potential 35mV) in control solution and during superfusion of
increasing concentrations of genistein (10, 30, and 100mM). (b) Time
course of If amplitude at 125mV; horizontal bars indicate the
period of drug superfusion at each concentration used. (c)
Concentration–response curve. Fitting of data points with the Hill
equation y¼ ymax*(1/(1þ (IC50/x)nH)) yielded a maximal fractional
inhibition (ymax) of 0.90, a half-block concentration (IC50) of 60.9 mM
and a Hill coefficient (nH) of 1.2. The numbers of patches tested at
the various concentrations are indicated near data points.
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example, genistein inhibits cardiac L-type calcium currents
in guinea-pig ventricular myocytes (Chiang et al., 1996), and
single-channel recordings in neonatal rat ventricular myocytes
show that genistein decreases the open probability of the
calcium channels without affecting the mean open time and
the conductance (Katsube et al., 1998). These data suggest
that there is a direct binding of the drug to the channel.
Furthermore, genistein (100 mM) abolishes the opening of
ATP-sensitive Kþ channels of the rabbit portal vein smooth
muscle cells by a mechanism that may involve a direct
inhibition (Ogata et al., 1997). Our data point to the
involvement of intracellular channel structures as sites for
drug binding. Several f-channel blockers such as zatebradine,
ZD7288, cilobradine, caesium, and ivabradine have been
described in the literature and their mechanisms of action
can be very complex (for a complete review, see Baruscotti
et al., 2005). For all these drugs, the affinities for f-channels are
variously influenced by several parameters such as voltage,
gating state, and current flow. For example, ivabradine, a
novel heart-rate-reducing agent, can access its binding site in
SAN native f-channels only when the channels are open, but
the inward current flow destabilizes the drug–channel interac-
tion, thus revealing a strong current dependence of the block
(Bucchi et al., 2002). Our data indicate that genistein
represents a case of a molecule that directly blocks f-channels,
whose affinity is independent of the functional state of the
channel. A similar result was found for alinidine (Van Bogaert
& Goethals, 1987), although a direct interaction was not
demonstrated.
Under physiological conditions genistein exists both in the
neutral and monoanionic forms, since the pKa value for
the first deprotonation reaction is 7.2 (Zielonka et al., 2003).
The lack of voltage dependence observed in our experiments
(Figure 4b) could be explained by assuming that genistein
interacts with the f-channels in the neutral form. More
intriguing is the lack of interference of the gating mechanism
on genistein block. Indeed, molecules such as ZD7288 or
ivabradine that directly block pacemaker channels from the
intracellular environment can be trapped by the channel gating
structures, thus suggesting the existence of a wide inner
hydrophilic vestibule near the inner mouth of the pore (Shin
et al., 2001; Bucchi et al., 2002). Genistein does not conform to
this type of behavior, thus suggesting that the gating structures
do not limit the access of the drug to the pore.
One additional hypothesis on the action of genistein on ionic
channels has been proposed by Hwang et al. (2003) these
authors provide evidence that genistein can alter the mechan-
ical properties of bilayers, and this would in turn influence the
gramicidin A channel function. Although this is an interesting
hypothesis, it still has to be confirmed in native cell membrane
and ionic channels.
Inhibitory drugs can modify whole-cell currents either by
shifting the voltage dependence of gating and/or by reducing
the maximal conductance. Experiments such as those
presented in Figure 7 clearly indicate that genistein acts on
f-channels by a strong reduction of the maximal conductance
and a minor, but still significant, modification of the voltage
dependence of the activation curve. Recently, Yu et al. (2004)
have shown that HCN clones are differently affected by
genistein; while genistein does not have any effect on HCN1, it
modifies HCN4 by selectively reducing maximal conductance,
and inhibits HCN2 by shifting its voltage dependence towards
more negative values. Since in rabbit SAN cells If is mostly
composed by HCN4 isoform (Shi et al., 1999; Altomare et al.,
2003), it is thus not surprising that the most evident inhibitory
mechanism shown in Figure 7 is a maximal conductance
reduction. Partially unexpected are the observed modifications
of the voltage-dependent parameters (V1/2 and s), that could be
linked to a limited presence of HCN2 isoforms. Although
HCN2 contribution to native sinoatrial f-current has been
excluded based on RNA detection methods (Shi et al., 1999),
a careful analysis of the presence and distribution of HCN
protein in the SA node is still missing. Thus, the presence of a
limited, yet relevant, functional participation of HCN2 to
native f-currents cannot be excluded.
The analysis of the primary sequences of HCN isoforms has
allowed Yu et al. (2004) to identify several tyrosine residues
that could be the target for the activity of tyrosine kinases.
Future experiments should therefore study the effect of
genistein and of phosphorylation on channels in which single
and/or combined mutation of these residues will be induced.
Such an approach is likely to shed light on the importance of
phosphorylating mechanism on the basal activity of HCN and
therefore of native f-channels.
In conclusion, our data provide a direct demonstration that
genistein inhibits f-channel activity by a direct interaction with
the intracellular side of the channel, and binding stability is
not influenced by the voltage and by the gating state of the
channel. The direct inhibition of If implies that genistein does
not represent a useful pharmacological tool to study the
implication of tyrosine kinase activity in the possible control of
f-channels by phosphorylating processes.
We should like to thank Dr DiFrancesco, Dr Bois, and Dr Viscomi for
productive discussions and encouragements.
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